2009 Press Releases

November 10, 2009
Independent Study Utilizing Cyclic Levulan PDT Finds 95 Percent Reduction in New Squamous Cell Carcinoma Lesions in Solid Organ Transplant Recipients Over a 2-Year Period

November 6, 2009
DUSA Pharmaceuticals Reports Third Quarter 2009 Corporate Highlights and Financial Results

November 6, 2009
DUSA Pharmaceuticals to Present at the Merriman Curhan Ford Investor Summit 2009

November 6, 2009
DUSA Pharmaceuticals Reports Third Quarter 2009 Corporate Highlights and Financial Results Conference Call

November 3, 2009
DUSA Pharmaceuticals, Inc.® Announces Third Quarter Financial Results and Corporate Highlights Conference Call

October 28, 2009
DUSA Pharmaceuticals Surpasses One Million in Cumulative Levulan® Kerastick® Sales Units

October 21, 2009
DUSA Pharmaceuticals Named to Deloitte’s 2009 Technology Fast 500 List of Fastest Growing Companies in North America

September 22, 2009
DUSA Pharmaceuticals to Present at the Maxim Group 3rd Annual Growth Conference

September 2, 2009
DUSA Pharmaceuticals to Present at the Rodman & Renshaw 11th Annual Healthcare Conference

August 11, 2009
DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results Conference Call